These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31987990)

  • 1. Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure.
    Engelmann C; Sheikh M; Sharma S; Kondo T; Loeffler-Wirth H; Zheng YB; Novelli S; Hall A; Kerbert AJC; Macnaughtan J; Mookerjee R; Habtesion A; Davies N; Ali T; Gupta S; Andreola F; Jalan R
    J Hepatol; 2020 Jul; 73(1):102-112. PubMed ID: 31987990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF.
    Engelmann C; Habtesion A; Hassan M; Kerbert AJ; Hammerich L; Novelli S; Fidaleo M; Philips A; Davies N; Ferreira-Gonzalez S; Forbes SJ; Berg T; Andreola F; Jalan R
    J Hepatol; 2022 Nov; 77(5):1325-1338. PubMed ID: 35843375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver Failure.
    Engelmann C; Adebayo D; Oria M; De Chiara F; Novelli S; Habtesion A; Davies N; Andreola F; Jalan R
    Sci Rep; 2020 Jan; 10(1):389. PubMed ID: 31942020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
    Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on the inhibition of the NLRP3 signaling pathway with Shengsan Jiedu Huayu decoction to alleviate inflammatory injury in rats with acute-on-chronic liver failure].
    Liu X; Meng JL; Wang MG; Mao DW; Dai M
    Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):354-362. PubMed ID: 38733191
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
    Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligustrazine disrupts lipopolysaccharide-activated NLRP3 inflammasome pathway associated with inhibition of Toll-like receptor 4 in hepatocytes.
    Zhang F; Jin H; Wu L; Shao J; Wu X; Lu Y; Zheng S
    Biomed Pharmacother; 2016 Mar; 78():204-209. PubMed ID: 26898443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of TLR4-MyD88 signaling promotes hepatic dysfunction and fibrotic changes in SD rats resulting from prolonged exposure to sodium arsenite.
    Song Q; Jin Y; He R; Fan L; Tu C; Chen X; Wang D
    Int Immunopharmacol; 2024 Oct; 140():112823. PubMed ID: 39083929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
    Lu L; Wu C; Lu BJ; Xie D; Wang Z; Bahaji Azami NL; An YT; Wang HJ; Ye G; Sun MY
    J Ethnopharmacol; 2020 Mar; 249():112301. PubMed ID: 31622746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYELOID-DERIVED TLR4-TRIF SIGNALING PATHWAY MEDIATES OXIDATIVE STRESS IN LPS/D-GALN-INDUCED ACUTE LIVER FAILURE.
    Li J; Jiang L; Zhao K; Tang Y; Yuan X; Xu Y
    Shock; 2024 Oct; 62(4):582-587. PubMed ID: 39158930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model.
    Sha T; Sunamoto M; Kitazaki T; Sato J; Ii M; Iizawa Y
    Eur J Pharmacol; 2007 Oct; 571(2-3):231-9. PubMed ID: 17632100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calycosin inhibits hepatocyte apoptosis in acute liver failure by suppressing the TLR4/NF-κB pathway: An in vitro study.
    Chang L; Zhang A; Liu W; Cao P; Dong L; Gao X
    Immun Inflamm Dis; 2023 Jul; 11(7):e935. PubMed ID: 37506138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.
    Chen L; Ren F; Zhang H; Wen T; Piao Z; Zhou L; Zheng S; Zhang J; Chen Y; Han Y; Duan Z; Ma Y
    PLoS One; 2012; 7(9):e45202. PubMed ID: 23028846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of oxymatrine on hepatocyte apoptosis
    Zhang X; Jiang W; Zhou AL; Zhao M; Jiang DR
    World J Gastroenterol; 2017 Jun; 23(21):3839-3849. PubMed ID: 28638224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses.
    Pfalzgraff A; Heinbockel L; Su Q; Brandenburg K; Weindl G
    Biochem Pharmacol; 2017 Sep; 140():64-72. PubMed ID: 28539262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
    Ii M; Matsunaga N; Hazeki K; Nakamura K; Takashima K; Seya T; Hazeki O; Kitazaki T; Iizawa Y
    Mol Pharmacol; 2006 Apr; 69(4):1288-95. PubMed ID: 16373689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.